CIK 0001367644 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 742.9 M | 1.1 B |
| Net income (USD) | 52.6 M | -211.6 M |
| Diluted EPS (USD/shares) | 0.93 | -4.22 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 8-K | 8-K CFO 10.16.2026 items 5.02,9.01 | 2026-10-16 |
| 2026-10-07 | 144 | 144 | |
| 2026-10-07 | 4 | FORM 4 | 2026-10-07 |
| 2026-10-05 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-01 | 144 | 144 | |
| 2026-09-14 | 8-K | 8-K items 7.01,9.01 | 2026-09-14 |
| 2026-09-01 | 8-K | 8-K items 8.01,9.01 | 2026-08-18 |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-12 | 3 | FORM 3 | 2026-08-05 |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,2.05,5.02,7.01,9.01 | 2026-08-05 |
| 2026-07-31 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-28 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-02 | 4 | FORM 4 | 2026-07-01 |
| 2026-07-01 | 144 | 144 | |
| 2026-06-29 | 8-K | 8-K items 1.01,7.01,9.01 | 2026-06-26 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-08 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-08 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-08 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-08 |
| 2026-05-04 | 4 | FORM 4 | 2026-04-30 |
| 2026-05-04 | 4 | FORM 4 | 2026-04-30 |
| 2026-05-04 | 4 | FORM 4 | 2026-04-30 |
| 2026-05-04 | 4 | FORM 4 | 2026-04-30 |
| 2026-05-04 | 4 | FORM 4 | 2026-04-30 |
Forms on file (last 1,000): 4 513, 8-K 195, SC 13G/A 45, CT ORDER 43, 10-Q 35, 3 24, 144 22, DEFA14A 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=EBS (0.002 USD), /gw/filings/filings?ticker=EBS&form=8-K, /gw/filings/facts?ticker=EBS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange